Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy

Publisher： Karger

E-ISSN： 1423-0097|166|1|41-51

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.166, Iss.1, 2015-02, pp. : 41-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Engineering of Recombinant Hypoallergenic Oligomers of the Major Birch Pollen Allergen, Bet v 1: Candidates for Specific Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 218-219

Karger

Access to resources Recommend Favorite

Characterization of a Hypoallergenic Recombinant Bet v 1 Variant as a Candidate for Allergen-Specific Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 145, Iss. 3, 2007-10 ,pp. : 193-206

Karger

Access to resources Recommend Favorite

Safety of Subcutaneous Specific Immunotherapy with Pollen Allergen Extracts for Respiratory Allergy

By  

International Archives of Allergy and Immunology, Vol. 132, Iss. 3, 2003-12 ,pp. : 258-262

Karger

Access to resources Recommend Favorite

An Observational Study on Outgrowing Food Allergy during Non-Birch Pollen-Specific, Subcutaneous Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 143, Iss. 3, 2007-02 ,pp. : 185-189

Karger

Access to resources Recommend Favorite

Analysis of an Unusual Cluster of Systemic Reactions to Subcutaneous Specific Immunotherapy with Respiratory Allergens in One Allergy Center

By  

International Archives of Allergy and Immunology, Vol. 157, Iss. 3, 2011-11 ,pp. : 318-320

Karger

Access to resources Recommend Favorite